USPTO serial 79214163
V-CRT
Reviewed by CopyMark Law Group
Reg. 5667678Status 708Registered
- Filing date
- Status date
- Registration date
- Feb 5, 2019
- Examiner
- DONEGAN, DANIEL P
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with V-CRT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Vetter Pharma-Fertigung GmbH & Co. KG
Ravensburg, DE
Other trademarks owned by Vetter Pharma-Fertigung GmbH & Co. KG
Vetter Pharma-Fertigung GmbH & Co. KG
DE
Other trademarks owned by Vetter Pharma-Fertigung GmbH & Co. KG
Vetter Pharma-Fertigung GmbH & Co. KG
DE
Other trademarks owned by Vetter Pharma-Fertigung GmbH & Co. KG
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
M. Scott Alprin
M. Scott Alprin Alprin Law Offices, P.C.5 Pinehurst Circle, N.W.Washington, DC 20015United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Aseptically manufactured pharmaceutical preparations and drugs, namely, orally administrable solutions, injectable solutions, solids and semisolids capable of being dissolved in liquids and solvents, powders in ready-to-use form or capable of reconstitution, all for use in the treatment of infections, cancer, depression, heart disease, vascular disease, intestinal disorder, lung and bronchial dysfunction, liver dysfunction, oral and laryngeal disease, optical and cranial disorders; pharmaceutical solutions to be taken orally, sterile aseptic solutions and injection solutions in forms suitable for sale and application, namely, pharmaceutical solutions, sterile aseptic solutions and injection solutions all for use in the treatment of infections, cancer, depression, heart disease, vascular disease, intestinal disorder, lung and bronchial dysfunction, liver dysfunction, or laryngeal disease, optical and cranial disorders; swabs for medical purposes, namely, non-impregnated cotton swabs, premoistened cotton swabs and cotton swabs impregnated with alcohol, iodine, sterilizing agents and cleaning solutions for medical purposes ] | SECTION 71 - CANCELLED | — |
| 039 | Aseptic, sterile bottling of substances | ACTIVE | — |
| 042 | [ Scientific and technical development of injection syringes and instruments, injectors and related packaging; chemical, physical and process engineering ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Vetter Pharma-Fertigung GmbH & Co. KG
- Other trademarks owned by Vetter Pharma-Fertigung GmbH & Co. KG
- Other trademarks owned by Vetter Pharma-Fertigung GmbH & Co. KG
- Other trademarks in Class 005
- Other trademarks in Class 039
- Other trademarks in Class 042
- Similar marks named V-CRT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 1, 2026 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Aug 9, 2026 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Dec 9, 2025 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Dec 9, 2025 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Dec 3, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 5, 2025 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Feb 5, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jun 21, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 31, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 31, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 5, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 5, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 1, 2019 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 16, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 16, 2019 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 20, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 20, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 16, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 31, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 31, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 31, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 18, 2018 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Oct 16, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 15, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 15, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 10, 2018 | ALIE | ASSIGNED TO LIE | — |
| Sep 26, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 19, 2018 | RFNP | REFUSAL PROCESSED BY IB | — |
| Mar 27, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 27, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 27, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 24, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 23, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 23, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 9, 2017 | RFNP | REFUSAL PROCESSED BY IB | — |
| Aug 23, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 23, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 22, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 19, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 18, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 16, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 16, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 10, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |